Category News

Bioscience

Bioscience Association Manitoba Joins Premier’s Workforce Development Subcommittee

Bioscience Association Manitoba Joins Premier’s Workforce Development Subcommittee to Shape the Future of Talent and Economic Growth In a significant step toward aligning Manitoba’s economic strategy with the demands of a rapidly evolving global marketplace, the Bioscience Association Manitoba (BAM)…

Read MoreBioscience Association Manitoba Joins Premier’s Workforce Development Subcommittee

Legend Biotech Showcases Recent Business Developments at 44th Annual J.P. Morgan Healthcare Conference

Legend Biotech Showcases Latest Business Developments at 44th Annual J.P. Morgan Healthcare Conference Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today provided an update on the Company’s recent commercial and clinical progress and outlined its…

Read MoreLegend Biotech Showcases Recent Business Developments at 44th Annual J.P. Morgan Healthcare Conference

WuXi Biologics Secures UK MHRA GMP Certification for Commercial Production of Ophthalmic Biologic

WuXi Biologics Secures UK MHRA GMP Certification for Commercial Production of Ophthalmic Biologic WuXi Biologics a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing facilities in Wuxi –Drug Product Facility 5 (DP5) and…

Read MoreWuXi Biologics Secures UK MHRA GMP Certification for Commercial Production of Ophthalmic Biologic

Royalty Pharma to Showcase Achievements and Business Update at J.P. Morgan Healthcare Conference

Royalty Pharma to Showcase Achievements and Share Business Update at J.P. Morgan Healthcare Conference Royalty Pharma plc today provided an update on its business performance, including recent key accomplishments. Pablo Legorreta, Royalty Pharma’s Chief Executive Officer and Chairman of the…

Read MoreRoyalty Pharma to Showcase Achievements and Business Update at J.P. Morgan Healthcare Conference

Biogen Secures European Commission Approval for High-Dose SPINRAZA® (nusinersen) Regimen in Spinal Muscular Atrophy

Biogen Secures European Commission Approval for High-Dose SPINRAZA® (nusinersen) Regimen in Spinal Muscular Atrophy Biogen Inc. today announced the European Commission (EC) has granted marketing authorization for a high dose regimen of SPINRAZA® (nusinersen) which is comprised of 50 mg/5 mL…

Read MoreBiogen Secures European Commission Approval for High-Dose SPINRAZA® (nusinersen) Regimen in Spinal Muscular Atrophy
Hippocratic

BCG and Hippocratic AI Form Strategic Alliance to Deploy Agentic AI in Biopharma and Medtech

BCG and Hippocratic AI Announce Strategic Collaboration to Deploy Agentic AI Across Biopharma and Medtech Boston Consulting Group (BCG) and Hippocratic AI today announced a global collaboration aimed at transforming the biopharma and medtech industries through the responsible implementation of…

Read MoreBCG and Hippocratic AI Form Strategic Alliance to Deploy Agentic AI in Biopharma and Medtech

Johnson & Johnson Delivers on U.S. Agreement to Lower Costs and Invest in Manufacturing and Innovation

The agreement aims to improve medicine affordability while supporting U.S.-based manufacturing and pharmaceutical innovation. Johnson & Johnson healthcare’s leading, most comprehensive innovation powerhouse, today announced a voluntary agreement with the Trump Administration to improve access to medicines and lower costs…

Read MoreJohnson & Johnson Delivers on U.S. Agreement to Lower Costs and Invest in Manufacturing and Innovation

Bayer and Soufflé Therapeutics Partner on Heart-Targeted siRNA

Collaboration focuses on advancing cell-specific siRNA therapies for cardiovascular disease treatment. Bayer and Soufflé Therapeutics™, an innovative biotech company that discovers and develops cell-selective genetic therapies, today announced a strategic collaboration and global licensing agreement to advance a heart-targeted small…

Read MoreBayer and Soufflé Therapeutics Partner on Heart-Targeted siRNA